Engineering of the Endogenous HBD promoter increases HbA2
Mandy Y. Boontanrart, Elia Mächler, Simone Ponta, Jan C Nelis, Viviana G Preiano, Jacob E. Corn
This study uses CRISPR-Cas9 to edit the endogenous {delta}-globin promoter to increase HbA2 expression in human erythroid cells, showing that multiple transcription factor elements are required for effective upregulation.
eLife · Jun 2, 2023Peer-reviewedGenetics